Firas Badin

机构：Central Baptist Hospital · ORCID：0009-0001-0693-3747

发表论文 38 篇 · 总被引 3164 次 · h-index 10

代表论文

• Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study (2024 · Journal of Clinical Oncology · 被引 126)
• LBA65 KRYSTAL-7: Efficacy and safety of adagrasib with pembrolizumab in patients with treatment-naïve, advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation (2023 · Annals of Oncology · 被引 53)
• Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysis (2023 · Lung Cancer · 被引 29)
• First-line adagrasib (ADA) with pembrolizumab (PEMBRO) in patients (pts) with advanced/metastatic KRAS G12C -mutated non-small cell lung cancer (NSCLC) from the phase 2 portion of the KRYSTAL-7 study. (2025 · Journal of Clinical Oncology · 被引 22)
• Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial (2025 · The Lancet Respiratory Medicine · 被引 11)
• Breast cancer quality of care in Syria: screening, diagnosis, and staging (2023 · BMC Cancer · 被引 10)